# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 7

Extent: E+W+S+N.I.

If there is a compatibility statement with other immunological products in the summary of product characteristics, the efficacy of the association shall be investigated. Any other known interactions with any other veterinary medicinal products shall be described. Concurrent or simultaneous use may be allowed if supported by appropriate studies.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/II/chapter/II/division/A/division/7 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-II/chapter-II/division-A/division-7
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.